Submit Deal

ANGITIA BIOPHARMACEUTICALS

HQ - Woodland Hills

Summary

Angitia is a clinical-stage biotechnology company focused on discovering and developing therapeutics for musculoskeletal diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 94 M

Avg. Deal Size£ 94 M

Market Context

Senior Management

Sort

Target: ANGITIA BIOPHARMACEUTICALS

Bidder: JANUS HENDERSON INVESTORS

3 Service Providers

2 Dealmakers

£ 94 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy